1. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy
   Xiujuan Xu et al, 2019, Radiation Oncology CrossRef
2. Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study
   Yuzhong Cui et al, 2022, Clinical and Translational Oncology CrossRef
3. Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT
   Geng Xiang et al, 2023, Radiation Oncology CrossRef
4. Efficacy and safety of re-irradiation for locoregional esophageal squamous cell carcinoma recurrence after radiotherapy: a systematic review and meta-analysis
   Kuntian Lan et al, 2022, Radiation Oncology CrossRef
5. Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees
   Michael D. Chuong et al, 2021, Frontiers in Oncology CrossRef
6. Assessing Outcomes of Patients Treated With Re-Irradiation Utilizing Proton Pencil-Beam Scanning for Primary or Recurrent Malignancies of the Esophagus and Gastroesophageal Junction
   Cristina M. DeCesaris et al, 2020, Journal of Thoracic Oncology CrossRef
7. A re-irradiation dose of 55–60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy
   Xun Wu et al, 2021, Radiation Oncology CrossRef
8. Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis
   Kaikai Zhao et al, 2020, Radiation Oncology CrossRef
9. Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site
   Xinran Wang et al, 2022, BMC Cancer CrossRef
10. Three-hole oesophagectomy following bilateral lung transplant for cystic fibrosis
    Roy Avraham Hilzenrat et al, 2022, BMJ Case Reports CrossRef
11. Definitive re‑irradiation of locally recurrent esophageal cancer after trimodality therapy in patients with a poor performance status
    Daniel Kim et al, 2020, Molecular and Clinical Oncology CrossRef
12. Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma
    Koichi Yagi et al, 2021, Annals of Gastroenterological Surgery CrossRef
13. Re-irradiation for intra-thoracic tumours and extra-thoracic breast cancer: dose accumulation, evaluation of efficacy and toxicity based on a literature review
    Dorota Gabrys et al, 2022, The British Journal of Radiology CrossRef
14. Antineoplastics
    , 2017, Reactions Weekly CrossRef